Why the CMS Hemp CBD Program Lawsuit Poses Real Legal Risk

April 14, 2026 8:20 AM

A recent article by Marijuana Moment suggests that the federal government's motion to dismiss litigation challenging the Centers for Medicare & Medicaid Services (CMS) hemp access initiative exposes weaknesses in the case brought by MMJ International Holdings and other plaintiffs. It does.Because, the government's motion confirms exactly why the lawsuit matters: CMS has created a federal cannabinoid access pathway inside Medicare infrastructure...

Read more

Rancho BioSciences Formally Appoints Amar Thyagarajan, PhD, as Chief Commercial Officer

April 14, 2026 8:00 AM

Rancho BioSciences today formally announced the appointment of Amar Thyagarajan, PhD, as Chief Commercial Officer. Dr. Thyagarajan, who joined Rancho BioSciences earlier this year, leads the company's global commercial strategy, including sales, marketing, strategic partnerships, and revenue growth across its scientific data services, products, and alliances.His appointment comes as life sciences organizations face increasing pressure to...

Read more

Sweden's Healthcare IT Market Enters a New Era Where Digital Maturity Alone Is No Longer Enough

April 14, 2026 7:40 AM

Black Book Research today announced the release of State of Digital Healthcare IT 2026: Sweden, a new market intelligence report examining the current state of healthcare IT adoption, vendor positioning, provider priorities, and digital modernization across Sweden's highly advanced but structurally decentralized healthcare system.Based on Black Book's 2026 survey of 404 Swedish healthcare leaders using IT in their facilities, the report finds...

Read more

CBD Life Sciences Inc. (CBDL) Announces Our Collection of Adaptogenic Mushroom Products

April 14, 2026 7:15 AM

CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the launch of Mushroom Madness. Our new line of natural mushroom supplements designed to support everyday wellness through convenient and enjoyable products. The collection includes Mushroom-infused Gummies, coffee blends, Topicals and Capsules made with carefully selected functional mushrooms known for their potential benefits in focus, energy, immune support, and...

Read more

Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives

April 14, 2026 7:05 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub supporting retail pharmacy, telemedicine, and specialty pharmaceutical programs.The execution of the joint...

Read more

Miltenyi Biotec's Antibodies Division Leverages Bioz Badges to Deliver Powerful Publication Visibility

April 14, 2026 4:00 AM

Bioz, Inc., a data-centric product validation platform for scientific research, announces the integration of Bioz Badges and the Bioz Shield across Miltenyi Biotec's antibodies division. Through this advanced implementation, Miltenyi Biotec is reinforcing its commitment to scientific transparency, data-driven validation, and a best-in-class researcher experience.Miltenyi Biotec's antibodies division, recognized globally for its high-quality...

Read more

BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)

April 14, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce the successful completion of Good Manufacturing Practice (GMP) manufacturing of its clinical-grade sublingual Cladribine oral thin film (ODF) at its GMP manufacturing partner (CDMO) based in Munich, Germany.The completed GMP production campaign represents a significant...

Read more

Hemogenyx Pharmaceuticals PLC Announces Annual IND Report with FDA

April 14, 2026 2:16 AM

Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has submitted its Annual Report to the U.S. Food and Drug Administration (FDA) under the active Investigational New Drug (IND) application for HG-CT-1, the Company's proprietary CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia (R/R AML).The annual report provides a comprehensive update on the Company's activities under the IND during the...

Read more

World Tumor Registry Launches Breast Cancer Registry

April 14, 2026 12:00 AM

The World Tumor Registry ("WTR"), a global non-profit organization with a mission to improve cancer patient outcomes through better diagnosis and education, announces the launch of its second project, the Breast Cancer Registry. This digital, open-access platform is designed to standardize and elevate the accuracy of breast cancer diagnoses worldwide. "With breast cancer affecting more lives than any other cancer in the U.S. and around the...

Read more

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

April 13, 2026 12:50 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has received a new purchase order for 60,000 units of its Sky Premium Life products from Pharmalink under the existing exclusive distribution agreement for the United Arab Emirates (UAE) market. This marks the third consecutive purchase order from Pharmalink, bringing cumulative orders to...

Read more

Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results

April 13, 2026 11:15 AM

Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today reported its financial results for its 2026 fiscal fourth quarter and year end.Encision's CEO Robert Fries commented, "The Company's sales were down 12% from the prior quarter. January and February's sales were below normal in part because of fewer...

Read more

Glidewell Launches the fastsmile.io(TM) 3D Facial Scanner

April 13, 2026 10:00 AM

Glidewell, the nation's largest dental laboratory and a leader in innovative technology, has unveiled the fastsmile.io™ 3D Facial Scanner. The fastsmile.io scanner enables clinicians to capture full-face 3D scans, enhancing esthetic treatment planning by combining facial data with intraoral scans for a more complete digital workflow.The fastsmile.io 3D Facial Scanner is a compact, high-speed imaging device that captures a complete 3D facial scan...

Read more

Avel eCare Appoints Rich Sanders as Chief Operating Officer

April 13, 2026 9:26 AM

Avel eCare is pleased to announce the appointment of Rich Sanders as Chief Operating Officer (COO), following his service as Interim COO over the past several months. In this role, Sanders will oversee enterprise operations, clinical service delivery, and cross-functional execution across Avel eCare's national portfolio of virtual care services.Sanders brings more than two decades of healthcare leadership experience, with a background spanning...

Read more

Dr. David W. Allison Brings His Expertise in Breast and Body Surgery to Becker Aesthetics & Plastic Surgery

April 13, 2026 9:00 AM

Dr. David W. Allison, a board-certified plastic surgeon with more than 23 years of experience specializing in breast and body surgery, is pleased to announce his addition to the team at Becker Aesthetics & Plastic Surgery, a physician-led plastic surgery and aesthetics clinic with a longstanding reputation for clinical excellence throughout New Jersey and the Philadelphia region. Dr. Allison now sees patients at the practice's Princeton, NJ and...

Read more

The Lifesaving Power of Stem Cell Donation Starts With Awareness

April 13, 2026 9:00 AM

Key pointsExpanding stem cell donor awareness, in addition to diversifying the registry, is a critical public health priority that determines whether patients receive life-saving treatments.Max, a 15 year-old waiting for a match, represents the thousands of patients who need someone from outside their family to be their lifeline.Becoming a stem cell donor is simple, accessible, and safe.Every three to four minutes in the United States, someone...

Read more

Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis

April 13, 2026 9:00 AM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced the publication of a peer-reviewed article in the scientific journal npjBiomedical Innovations , published by Springer Nature, which highlights the potential of RNA based therapies in conjunction with advanced delivery platforms in the treatment of...

Read more

Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs

April 13, 2026 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that it plans to use AI platforms to enhance its development, commercialization, and healthcare delivery objectives for crofelemer programs for the treatment of intestinal failure in both adult and pediatric patients."Our IF program in MVID could leverage AI platforms that could help guide personalized regimens for each patient for this ultrarare disease and include real-world evidence to support...

Read more

Black Book Research Releases Poland State of Digital Healthcare IT 2026 Market Report

April 13, 2026 7:15 AM

Black Book Research today announced the release of State of Digital Healthcare IT: Poland 2026, a new Q1 2026 market report examining the next phase of healthcare IT modernization across one of Europe's most nationally coordinated digital health markets.The report concludes that Poland is no longer an emerging digital health market. It is a maturing e-health environment built on a strong national backbone for e-prescriptions, e-referrals,...

Read more

MMJ International Holdings Seeks Injunction to Halt CMS CBD Program

April 13, 2026 6:00 AM

MMJ International Holdings, Inc. (MMJIH), a pharmaceutical cannabinoid developer advancing therapies for Huntington's disease and Multiple Sclerosis, today issued a strong warning regarding the legality and safety implications of the Centers for Medicare & Medicaid Services' (CMS) newly launched Substance Access Beneficiary Engagement Incentive (BEI) program - a federal initiative now under challenge in the U.S. District Court for the District...

Read more

iZafe Group Achieves ISO/IEC 27001 Certification and Strengthens Its Position for International Expansion

April 13, 2026 5:20 AM

iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ) today announces that the company has obtained certification according to the international ISO/IEC 27001 standard for information security. The certification covers all companies within the group: iZafe Group, Dosell Sweden, Dosell Netherlands, and Pilloxa, and includes the development, operation, and delivery of the company's products and services.ISO/IEC 27001 is a globally recognized standard...

Read more